AACR, ASCO Bring New Insights to Liquid BiopsyByAndy CollardJune 13th 2018Applied Clinical TrialsLiquid biopsy, typically non-invasive blood-based tests for circulating tumor DNA and circulating tumor cells, has been long-hyped as a potential game-changer for cancer treatment.